Mitochondrial DNA decrease in subcutaneous adipose tissue of HIV-infected individuals with peripheral lipoatrophy

AIDS

Volumn 15, Issue 14, 2001, Pages 1801-1809

  Shikuma, Cecilia M ^a,b   Hu, Ningjie ^a   Milne, Cris ^b   Yost, Frederick ^b   Waslien, Carol ^b   Shimizu, Sheri ^b   Shiramizu, Bruce ^a,b  

^a UNIVERSITY OF HAWAII   (United States)

^b UNIVERSITY OF HAWAII   (United States)

Author keywords

Antiretroviral therapy; Lipodystrophy; Mitochondria; Reverse transcriptase inhibitors

Indexed keywords

DIDANOSINE; DNA FRAGMENT; LAMIVUDINE; MITOCHONDRIAL DNA; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; ZIDOVUDINE;

ABDOMEN; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE INSERTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIPOATROPHY; LIPODYSTROPHY; MALE; NECK; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SUBCUTANEOUS FAT; THIGH;

ADIPOSE TISSUE; ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DNA, MITOCHONDRIAL; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; LIPODYSTROPHY; MALE; MIDDLE AGED; MITOCHONDRIA; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 0035964717     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200109280-00009     Document Type: Article

References (23)

1. A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: Contribution to protease inhibitor-related lipodystrophy syndrome
2. Reaching a consensus
3. Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy
4. Nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity as an etiology for lipodystrophy
5. Adverse effects of reverse transcriptase inhibitors: Mitochondrial toxicity as common pathway
6. Mitochondrial toxicity of antiviral drugs
7. A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy
8. Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy
9. Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection
10. Reversibility of peripheral fat wasting (lipodystrophy) on stopping stavudine therapy
11. The effects of discontinuing stavudine therapy on clinical and metabolic abnormalities in patients suffering from lipodystrophy
12. Rapid mapping of mitochondrial dna deletions by large-fragment PCR
13. Sequence and organization of the human mitochondrial genome
14. Detection and analysis of mitochondrial DNA deletions by whole genome PCR
15. Mitochondrial DNA. Small, beautiful and essential
16. Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity
17. Mitochondrial DNA mutations in multiple symmetric lipomatosis
18. Mitochondrial dysfunction with myoclonus epilepsy and ragged-red fibers point mutation in nerve, muscle, and adipose tissue of a patient with multiple symmetric lipomatosis
19. Defects of mitochondrial respiratory chain in multiple symmetric lipomatosis